Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial. - Paller AS; Cork MJ; Hong HC; Soong W; Schneider SKR; Lo H; Vinther F; Thøgersen P; Wollenberg A (Dermatology and therapy, 2026)